These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2763022)

  • 41. The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region.
    Onaran Y; Tezelman S; Gürel N; Terzioğlu T; Oğuz H; Tanakol R; Kapran Y
    Acta Chir Belg; 1999 Feb; 99(1):30-5. PubMed ID: 10090961
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mammary carcinoma. Comparison of nuclear DNA content from in situ and infiltrative components.
    Erhardt K; Auer GU
    Anal Quant Cytol Histol; 1987 Jun; 9(3):263-7. PubMed ID: 3040031
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Flow cytometric determination of breast tumor heterogeneity.
    Fuhr JE; Frye A; Kattine AA; Van Meter S
    Cancer; 1991 Mar; 67(5):1401-5. PubMed ID: 1846776
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Flow cytometric analysis of DNA content as a prognostic indicator in squamous cell carcinoma of the tongue.
    Sickle-Santanello BJ; Farrar WB; Dobson JL; O'Toole RV; Keyhani-Rofagha S
    Am J Surg; 1986 Oct; 152(4):393-5. PubMed ID: 3766869
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuclear DNA content, histological grade, and clinical course in patients with nonpalpable mammographically detected breast adenocarcinomas.
    Azavedo E; Fallenius A; Svane G; Auer G
    Am J Clin Oncol; 1990 Feb; 13(1):23-7. PubMed ID: 2154920
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up.
    Rosen PP; Groshen S; Kinne DW; Norton L
    J Clin Oncol; 1993 Nov; 11(11):2090-100. PubMed ID: 8229123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation between automated DNA ploidy measurements of Hürthle-cell tumors and their histopathologic and clinical features.
    Galera-Davidson H; Bibbo M; Bartels PH; Dytch HE; Puls JH; Wied GL
    Anal Quant Cytol Histol; 1986 Jun; 8(2):158-67. PubMed ID: 3730089
    [TBL] [Abstract][Full Text] [Related]  

  • 48. DNA aneuploidy in anaplastic carcinoma of the thyroid gland.
    Klemi PJ; Joensuu H; Eerola E
    Am J Clin Pathol; 1988 Feb; 89(2):154-9. PubMed ID: 3341277
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nuclear DNA content in mammary carcinomas in women aged 35 or younger.
    von Rosen A; Fallenius A; Sundelin B; Auer G
    Am J Clin Oncol; 1986 Oct; 9(5):382-6. PubMed ID: 3022573
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA distributions in human normal, precancerous and cancerous breast tissue. II. Differences in heparin mediated changes in DNA distributions.
    Weiss H; Kunde D; Streller B
    Oncology; 1988; 45(3):214-23. PubMed ID: 3368198
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nuclear DNA content by cytofluorometry of stage I adenocarcinoma of the lung in relation to postoperative recurrence.
    Asamura H; Nakajima T; Mukai K; Shimosato Y
    Chest; 1989 Aug; 96(2):312-8. PubMed ID: 2752813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced telomere DNA content is correlated with genomic instability and metastasis in invasive human breast carcinoma.
    Griffith JK; Bryant JE; Fordyce CA; Gilliland FD; Joste NE; Moyzis RK
    Breast Cancer Res Treat; 1999 Mar; 54(1):59-64. PubMed ID: 10369081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear DNA content and survival in medullary thyroid carcinoma. Swedish Medullary Thyroid Cancer Study Group.
    Ekman ET; Bergholm U; Bäckdahl M; Adami HO; Bergström R; Grimelius L; Auer G
    Cancer; 1990 Feb; 65(3):511-7. PubMed ID: 2297642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma.
    Erhardt K; Auer G; Fallenius A; Folin A; Forsslund G; Silfverswärd C; Zetterberg A
    Am J Clin Oncol; 1986 Apr; 9(2):117-25. PubMed ID: 3012992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicentric adult secretory breast carcinoma: DNA flow cytometric findings, prognostic features, and review of the world literature.
    Richard G; Hawk JC; Baker AS; Austin RM
    J Surg Oncol; 1990 Aug; 44(4):238-44. PubMed ID: 2200927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular endothelial growth factor in the serum of breast cancer patients.
    Berezov TT; Ovchinnikova LK; Kuznetsova OM; Karabekova ZK; Vorotnikov IK; Tuleuova AA; Katunina AI; Dvorova EK
    Bull Exp Biol Med; 2009 Sep; 148(3):419-24. PubMed ID: 20396703
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of aneuploidy in melanoma of the extremity.
    van Oven MW; Baas PC; Oosterhuis JW; Schraffordt Koops H; Dam-Meiring A
    Cancer; 1992 Jul; 70(1):109-13. PubMed ID: 1606531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison between slide and flow cytophotometric DNA measurements in breast tumors.
    Auer GU; Askensten U; Erhardt K; Fallenius A; Zetterberg A
    Anal Quant Cytol Histol; 1987 May; 9(2):138-46. PubMed ID: 3606774
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flow Cytometric Analysis to Assess the Malignant Potential of Phyllodes Tumor.
    Tomita S; Deguchi S; Kusano T; Muto Y; Tamaki N; Nagamine Y
    Breast Cancer; 1994 Dec; 1(2):139-131. PubMed ID: 11091522
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognostic value of cytometric DNA analysis in early stage tongue cancer.
    Munck-Wikland E; Kuylenstierna R; Lind M; Lindholm J; Nathanson A; Auer G
    Eur J Cancer B Oral Oncol; 1992 Oct; 28B(2):135-8. PubMed ID: 1306730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.